Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 191

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

The Global Meningococcal Initiative meeting on prevention of meningococcal disease worldwide: Epidemiology, surveillance, hypervirulent strains, antibiotic resistance and high-risk populations

Open access
Acevedo, Reinaldo, Bai, Xilian, Borrow, Ray, Caugant, Dominique A., Carlos, Josefina, Ceyhan, Mehmet, Christensen, Hannah, Climent, Yanet, De Wals, Philippe, Dinleyici, Ener Cagri, Echaniz-Aviles, Gabriela, Hakawi, Ahmed, Kamiya, Hajime, Karachaliou, Andromachi, Lucidarme, Jay, Meiring, Susan, Mironov, Konstantin, Sáfadi, Marco A. P., Shao, Zhujun, Smith, Vinny, Steffen, Robert, Stenmark, Bianca, Taha, Muhamed-Kheir, Trotter, Caroline, Vázquez, Julio A., Zhu, Bingqing · 2019 · Expert Review of Vaccines

Abstract

INTRODUCTION: The 2018 Global Meningococcal Initiative (GMI) meeting focused on evolving invasive meningococcal disease (IMD) epidemiology, surveillance, and protection strategies worldwide, with emphasis on emerging antibiotic resistance and protection of high-risk populations. The GMI is comprised of a multidisciplinary group of scientists and clinicians representing institutions from several continents. AREAS COVERED: Given that the incidence and prevalence of IMD continually varies both geographically and temporally, and surveillance systems differ worldwide, the true burden of IMD remains unknown. Genomic alterations may increase the epidemic potential of meningococcal strains. Vaccination and (to a lesser extent) antimicrobial prophylaxis are the mainstays of IMD prevention. Experiences from across the globe advocate the use of conjugate vaccines, with promising evidence growing for protein vaccines. Multivalent vaccines can broaden protection against IMD. Application of protection strategies to high-risk groups, including individuals with asplenia, complement deficiencies and human immunodeficiency virus, laboratory workers, persons receiving eculizumab, and men who have sex with men, as well as attendees at mass gatherings, may prevent outbreaks. There was, however, evidence that reduced susceptibility to antibiotics was increasing worldwide. EXPERT COMMENTARY: The current GMI global recommendations were reinforced, with several other global initiatives underway to support IMD protection and prevention.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1080/14760584.2019.1557520

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Research works printed but not linked: 159

  1. 10.1086/322587 · DOI
  2. 10.1016/j.vaccine.2011.12.062 · DOI · Paper page
  3. 10.1038/nrmicro3093 · DOI · Paper page
  4. 10.1016/j.vaccine.2011.02.058 · DOI
  5. 10.1016/j.jinf.2018.01.007 · DOI
  6. 10.1016/j.jinf.2017.04.007 · DOI
  7. 10.4103/2249-4863.184616 · DOI
  8. 10.1128/JCM.00445-18 · DOI
  9. Centers for Disease Control and Prevention [Internet], Meeting of the Advisory Committee on Immunization Practices (ACIP) February 2017 Agenda
  10. Reported IMD incidence in Canada by serogroup, 1995–2015 [slides] 2018
  11. 10.1016/j.vaccine.2014.10.072 · doi:10.1016/j.vaccine.2014.10.072
  12. Koroleva I, Korolev MA, Beloshitsky GV, 2017, [Meningococcal infection and purulent bacterial meningitis in the Russian Federation in 2016: analytical review]
  13. The Institute of Environmental Science and Research Ltd. [Internet], Notifiable diseases in New Zealand annual report 2016
  14. National Institute for Communicable Diseases [Internet], GERMS South Africa annual report 2016
  15. Centers for Disease Control R.O.C (Taiwan) [Internet], Meningococcal Meningitis
  16. 10.1016/j.vaccine.2016.06.018 · doi:10.1016/j.vaccine.2016.06.018
  17. 10.1093/jpids/piu027 · DOI
  18. 10.1093/cid/civ597 · DOI
  19. 10.7189/jogh.06.020409 · doi:10.7189/jogh.06.020409
  20. 10.1016/S1473-3099(17)30301-8 · DOI · Paper page
  21. 10.1016/S1473-3099(15)00217-0 · DOI
  22. 10.1016/j.vaccine.2006.11.018 · DOI
  23. 10.26719/2016.22.5.343 · doi:10.26719/2016.22.5.343
  24. 10.1016/j.vaccine.2017.03.027 · DOI
  25. Matosova SV, 2014, Epidemiologiya i Infektsionnyie Bolezni, 2, 52
  26. Pan American Health Organization [Internet], 2018, Informe regional de SIREVA II, 2014. Datos por país y por grupos de edad sobre las características de los aislamientos de Streptococcus pneumoniae, Haemophilus influenzae y Neisseria meningitidis, en procesos invasivos bacterianos
  27. 10.1080/21645515.2017.1415682 · DOI
  28. (CBHI). TCBoHI [Internet], National health profile 2017 India
  29. 10.1371/currents.outbreaks.b50c2aaf1032b3ccade0fca0b63ee518 · DOI
  30. 10.3201/eid2210.160468 · DOI
  31. National Institute of Infectious Diseases Japan [Internet], Invasive meningococcal infection, April 2013–October 2017, Japan
  32. 10.1371/journal.pone.0019717 · DOI
  33. 10.1016/j.jinf.2015.07.007 · DOI · Paper page
  34. 10.3201/eid1909.130160 · doi:10.3201/eid1909.130160
  35. International Pathogenic Neisseria Conference [Internet], 20th International Pathogenic Neisseria Conference Abstracts Manchester
  36. 10.1177/2051013616650158 · doi:10.1177/2051013616650158
  37. 10.1080/21645515.2015.1051276 · DOI
  38. 10.1128/JCM.01409-17 · DOI
  39. 10.1016/S2468-2667(17)30157-3 · doi:10.1016/s2468-2667(17)30157-3
  40. Jafri RZ, 2013, Popul Health Metr, 11, 1
  41. 10.1093/cid/ciu057 · DOI
  42. 10.1371/journal.pone.0058065 · doi:10.1371/journal.pone.0058065
  43. Smaoui H, 2011, Archs Inst Pasteur Tunis, 88, 35
  44. 10.1080/21645515.2016.1268304 · DOI
  45. 10.1016/S0140-6736(08)60350-5 · doi:10.1016/s0140-6736(08)60350-5
  46. 10.1016/j.jinf.2017.10.015 · doi:10.1016/j.jinf.2017.10.015
  47. 10.2807/1560-7917.ES.2016.21.45.30395 · DOI
  48. 10.1038/srep41126 · DOI
  49. 10.3201/eid2308.170259 · doi:10.3201/eid2308.170259
  50. 10.2807/1560-7917.ES.2017.22.28.30574 · doi:10.2807/1560-7917.es.2017.22.28.30574
  51. 10.1001/jama.1995.03520290042027 · DOI · Paper page
  52. Krizova P, 1995, Cent Eur J Public Health, 3, 189
  53. 10.1136/bmj.324.7341.809 · DOI
  54. 10.1186/s12864-018-4560-x · DOI
  55. 10.1073/pnas.1620971114 · doi:10.1073/pnas.1620971114
  56. 10.1093/gbe/evw122 · DOI
  57. 10.1016/j.jinf.2017.05.015 · DOI
  58. 10.1016/j.ijid.2018.01.019 · DOI
  59. 10.1093/cid/cix215 · doi:10.1093/cid/cix215
  60. 10.1371/journal.pone.0154047 · DOI
  61. New Jersey Department of Health [Internet], Meningococcal invasive disease FAQ
  62. 10.1056/NEJMoa1514866 · DOI
  63. 10.3201/eid2305.161870 · doi:10.3201/eid2305.161870
  64. Centers for Disease Control and Prevention [Internet], Meeting of the Advisory Comittee on Immunization Practices (ACIP) October 2016 Agenda
  65. 10.1016/S1473-3099(16)30253-5 · DOI
  66. 10.15585/mmwr.mm6642a5 · DOI
  67. 10.1016/S1473-3099(18)30476-6 · doi:10.1016/s1473-3099(18)30476-6
  68. 10.1073/pnas.1802298115 · DOI
  69. 10.3346/jkms.2003.18.2.163 · doi:10.3346/jkms.2003.18.2.163
  70. 10.1016/S0140-6736(06)68141-5 · doi:10.1016/s0140-6736(06)68141-5
  71. 10.3201/eid2106.140687 · doi:10.3201/eid2106.140687
  72. 10.1038/nri2494 · DOI · Paper page
  73. 10.1086/527401 · DOI · Paper page
  74. 10.1586/erv.10.3 · DOI
  75. Granoff DM, 2012, Vaccines, 388
  76. Menjugate® (Meningococcal group C-CRM197 conjugate vaccine), 2013, Product monograph, novartis vaccines and diagnostics S.r.l.
  77. Meningitec®(Meningococcal Serogroup C Conjugate Vaccine), 2011, Product information
  78. Menitorix® (Haemophilus influenzae type b Polyribose ribitol phosphate and serogroup C Meningococcal polysaccharide conjugate vaccine [Hib-MenC]), 2016, Product information
  79. MenAfriVac® (Meningococcal A conjugate vaccine), 2011, Package insert
  80. Menactra® (Meningococcal [Groups A C, Y and W–135] Polysaccharide Diphtheria Toxoid Conjugate Vaccine), 2016, Highlights of prescribing information
  81. Menveo® (Meningococcal [Groups A C, Y and W–135] Oligosaccharide Diphtheria CRM197 Conjugate Vaccine), 2013, Highlights of prescribing information
  82. Nimenrix® (Meningococcal polysaccharide serogroups A CNovartis Vaccines and Diagnostics S.r.l., W–135 and Y conjugate vaccine), 2014, Consumer medicine information
  83. Mencevax ACWY® (Serogroups A C, W–135 and Y polysaccharide meningococcal vaccine), 2015, Product information
  84. Menomune® (A/C/Y/W–135 meningococcal polysaccharide vaccine), 2016, Highlights of prescribing information
  85. NeisVac-C® (Meningococcal Group C-TT Conjugate Vaccine­), 2015, Consumer information
  86. 10.3201/eid2307.170236 · DOI
  87. Govern d’Andorra [Internet], Pla de vacunacions
  88. Ministero della Salute [Internet], Piano nazionale prevenzione vaccinale PNPV 2017–2019
  89. HSE Immunisation [Internet], Immunisation guidelines for ireland: meningococcal infection
  90. Ministry of Health of The Republic of Lithuania [Internet], Official: children in Lithuania will be vaccinated against type B meningococcus
  91. 10.1016/S0264-410X(01)00299-7 · DOI · Paper page
  92. Public Health England, 2018, [slides] Any Impact on serogroup W?
  93. 10.3201/eid2306.161768 · doi:10.3201/eid2306.161768
  94. 10.1093/cid/cis892 · DOI · Paper page
  95. 10.1016/S0140-6736(13)61612-8 · DOI · Paper page
  96. Kristiansen PA, 2014, BMC Infect Dis, 14, 1
  97. 10.3201/eid2101.140256 · DOI
  98. 10.1093/infdis/126.5.514 · DOI · Paper page
  99. 10.4161/hv.24129 · DOI · Paper page
  100. 10.1016/j.vaccine.2017.05.065 · doi:10.1016/j.vaccine.2017.05.065
  101. 10.1126/science.287.5459.1809 · DOI · Paper page
  102. 10.1016/S0264-410X(00)00554-5 · DOI
  103. 10.1126/science.287.5459.1816 · DOI · Paper page
  104. 10.1016/S0140-6736(14)60842-4 · DOI · Paper page
  105. 10.1016/S2352-4642(18)30103-2 · DOI
  106. 10.1136/archdischild-2017-312941 · DOI
  107. 10.3201/eid2202.150369 · DOI
  108. Borrow R, 2018, 2018; MRF Meningitis Symposium
  109. 10.1080/21645515.2018.1438028 · doi:10.1080/21645515.2018.1438028
  110. Ochoa-Azze R, 2016, Vacci Monitor, 25, 43
  111. Pérez Rodriguez A, 1999, Mem Inst Oswaldo Cruz, 94, 440
  112. Sotolongo FS, 2007, MEDICC Rev, 9, 16, 10.37757/MR2007V9.N1.6 · DOI
  113. Echeverry Uribe M, 1995, Biol Oficina Sanit Panam, 118, 295
  114. 10.1097/00006454-200111000-00010 · doi:10.1097/00006454-200111000-00010
  115. Camaraza M, 2004, Rev Cubana Med Trop, 56, 26
  116. 10.1016/j.meegid.2010.02.002 · doi:10.1016/j.meegid.2010.02.002
  117. 10.1128/JCM.01653-09 · doi:10.1128/jcm.01653-09
  118. 10.1111/j.1365-2958.1989.tb01802.x · DOI
  119. 10.1111/j.1600-0463.2012.02903.x · DOI
  120. 10.1371/journal.ppat.1003528 · DOI
  121. 10.1016/S0140-6736(17)31449-6 · DOI · Paper page
  122. Minesterio de Salud Pública (MINSAP) Cuba [Internet], National office of statistics data
  123. 10.1093/ofid/ofx180.002 · doi:10.1093/ofid/ofx180.002
  124. 10.1542/peds.2016-2084 · DOI
  125. 10.1016/j.vaccine.2017.03.002 · DOI
  126. 10.4161/hv.2.2.2611 · DOI
  127. 10.1093/cid/civ508 · DOI
  128. 10.1016/j.vaccine.2016.11.076 · doi:10.1016/j.vaccine.2016.11.076
  129. 10.1128/CVI.00549-10 · doi:10.1128/cvi.00549-10
  130. Mueller J, 2013, Poster presented at: Meningitis Research Foundation Conference
  131. Yaro S, 2017, Poster presented at: Meningococcal Research Foundation Conference
  132. 10.1074/jbc.M304607200 · doi:10.1074/jbc.m304607200
  133. 10.1093/jac/dkw400 · doi:10.1093/jac/dkw400
  134. 10.1128/AAC.00412-07 · DOI
  135. 10.1128/AAC.00315-10 · DOI
  136. 10.1128/AAC.02184-12 · DOI
  137. 10.3201/eid1310.060820 · doi:10.3201/eid1310.060820
  138. 10.1099/jmm.0.078600-0 · DOI
  139. 10.1371/journal.pmed.1001838 · doi:10.1371/journal.pmed.1001838
  140. Centers for Disease Control and Prevention [Internet], 2018, Active bacterial core surveillance (ABCs) surveillance reports
  141. 10.1128/IAI.72.1.332-337.2004 · DOI
  142. 10.1093/cid/ciy141 · DOI
  143. Centers for Disease Control and Prevention [Internet], Meeting of the Advisory Committee on Immunization Practices (ACIP) summary report: rationale and proposed recommendations for revaccination of persons at increased risk for meningococcal disease (presentation summary)
  144. 10.1086/515075 · DOI · Paper page
  145. 10.1097/00006454-199310000-00002 · DOI
  146. 10.15585/mmwr.mm6543a3 · DOI
  147. 10.15585/mmwr.mm6627e1 · DOI · Paper page
  148. 10.1128/JCM.43.9.4811-4814.2005 · doi:10.1128/jcm.43.9.4811-4814.2005
  149. 10.1016/j.vaccine.2018.06.027 · DOI
  150. 10.3201/eid2305.161713 · DOI
  151. 10.1016/j.ijid.2016.04.007 · doi:10.1016/j.ijid.2016.04.007
  152. 10.1016/S0140-6736(87)91056-7 · DOI
  153. 10.3201/eid0906.020565 · doi:10.3201/eid0906.020565
  154. 10.26719/2013.19.4.389 · doi:10.26719/2013.19.4.389
  155. 10.1016/j.tmaid.2009.05.003 · DOI
  156. Folkehelseinstituttet [Internet], Ungdom og vaksine mot smittsom hjernehinnebetennelse
  157. 10.5365/wpsar.2016.7.3.007 · doi:10.5365/wpsar.2016.7.3.007
  158. Hachisu Y, 2017, Poster presented at: ID Week
  159. 10.1016/j.ijid.2016.03.007 · doi:10.1016/j.ijid.2016.03.007

Cited by

See all 191

Metadata

Authors
Acevedo, R., Bai, X., Borrow, R., Caugant, D. A., Carlos, J., Ceyhan, M., Christensen, H., Climent, Y., De Wals, P., Dinleyici, E. C., Echaniz-Aviles, G., Hakawi, A., Kamiya, H., Karachaliou, A., Lucidarme, J., Meiring, S., Mironov, K., Sáfadi, M. A. P., Shao, Z., Smith, V., Steffen, R., Stenmark, B., Taha, M.-K., Trotter, C., Vázquez, J. A., & Zhu, B.
Venue
Expert Review of Vaccines
Published
2018-12-27
Volume
18
Issue
1
Pages
15-30
ISSN
  • 1476-0584 (ISSN-L)
  • 1744-8395
OpenAlex
W2905534193
Cited by
191
References
4
FWCI
14.69
Type
journal article
Language
en
Open access
hybrid
Funders
supported by Sanofi Pasteur (N/A)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The Global Meningococcal Initiative meeting on prevention of meningococcal disease worldwide: Epidemiology, surveillance, hypervirulent strains, antibiotic resistance and high-risk populations. https://app.cochat.ai/papers/10.1080/14760584.2019.1557520
The paper
Acevedo, R., Bai, X., Borrow, R., Caugant, D. A., Carlos, J., Ceyhan, M., Christensen, H., Climent, Y., De Wals, P., Dinleyici, E. C., Echaniz-Aviles, G., Hakawi, A., Kamiya, H., Karachaliou, A., Lucidarme, J., Meiring, S., Mironov, K., Sáfadi, M. A. P., Shao, Z., . . . Zhu, B. (2019). The Global Meningococcal Initiative meeting on prevention of meningococcal disease worldwide: Epidemiology, surveillance, hypervirulent strains, antibiotic resistance and high-risk populations. Expert Review of Vaccines. https://doi.org/10.1080/14760584.2019.1557520

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.